Korean Firms Readying To Compete In Global GLP-1 Obesity Space

Hanmi Leading With Phase III Trial

obesity drugs
Several Korean Firms Vying In GLP-1 Drug Race • Source: Shutterstock

More from South Korea

More from Focus On Asia